Clinical Impact of Fingolimod-Associated Lymphopenia in Multiple Sclerosis: A Real-World Cohort Study

Murat Yeniçeri, Mustafa Can Şenoymak, Süleyman Baş, Hasan Hakan Çoban, Ayşe Gürbüz Yeniçeri, Serkan Demir, Alpaslan Tanoglu

Open source

DOI
10.3390/medicina62091716
Published
2026-09-07
Container
Medicina
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/medicina62091716,
  title = {Clinical Impact of Fingolimod-Associated Lymphopenia in Multiple Sclerosis: A Real-World Cohort Study},
  author = {Murat Yeniçeri and Mustafa Can Şenoymak and Süleyman Baş and Hasan Hakan Çoban and Ayşe Gürbüz Yeniçeri and Serkan Demir and Alpaslan Tanoglu},
  year = {2026},
  journal = {Medicina},
  doi = {10.3390/medicina62091716},
  url = {https://doi.org/10.3390/medicina62091716}
}

RIS

TY  - JOUR
TI  - Clinical Impact of Fingolimod-Associated Lymphopenia in Multiple Sclerosis: A Real-World Cohort Study
AU  - Murat Yeniçeri
AU  - Mustafa Can Şenoymak
AU  - Süleyman Baş
AU  - Hasan Hakan Çoban
AU  - Ayşe Gürbüz Yeniçeri
AU  - Serkan Demir
AU  - Alpaslan Tanoglu
PY  - 2026
JO  - Medicina
DO  - 10.3390/medicina62091716
UR  - https://doi.org/10.3390/medicina62091716
ER  - 

APA

Yeniçeri, M., Şenoymak, M. C., Baş, S., Çoban, H. H., Yeniçeri, A. G., Demir, S., & Tanoglu, A. (2026). Clinical Impact of Fingolimod-Associated Lymphopenia in Multiple Sclerosis: A Real-World Cohort Study. Medicina. https://doi.org/10.3390/medicina62091716

Source records